142 results on '"Llàcer, Pau"'
Search Results
2. High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure
3. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes
4. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations
5. Consenso sobre el abordaje de la sobrecarga hidrosalina en insuficiencia cardiaca aguda. Recomendaciones SEMI/SEC/S.E.N.
6. Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure
7. Morbimortalidad no cardiovascular en función de la fracción de eyección del ventrículo izquierdo tras una hospitalización por insuficiencia cardiaca
8. Prognosis of acute heart failure in patients followed up in nursing homes in Spain: Results from the RICA registry
9. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry
10. Prevalencia y perfil clínico de la enfermedad renal en pacientes con insuficiencia cardiaca crónica. Datos del Registro cardiorrenal español
11. Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction
12. Índice cronotrópico y eventos adversos a largo plazo en insuficiencia cardiaca con fracción de eyección conservada
13. Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study
14. Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction
15. Antígeno carbohidrato 125 (CA125) como marcador pronóstico en ancianos con insuficiencia cardiaca aguda y fracción de eyección preservada
16. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure
17. Punto de corte óptimo del antígeno carbohidrato 125 para la identificación de pacientes con bajo riesgo tras un ingreso por insuficiencia cardiaca aguda
18. Prognostic Impact of Statins in Heart Failure with Preserved Ejection Fraction.
19. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT‐HF trial.
20. Recomendaciones para desarrollar Modelos Asistenciales de atención al paciente con Insuficiencia Cardiaca (Proyecto MAIC): Estudio Delphi
21. Trimethylguanosine synthase 1 is a novel regulator of pancreatic beta-cell mass and function
22. Factores clave para modelos de atención a la insuficiencia cardiaca. Una visión integradora y multidisciplinar
23. Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure
24. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure
25. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction
26. Trayectoria precoz del sodio urinario y riesgo de eventos adversos en insuficiencia cardiaca aguda y disfunción renal
27. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure
28. Comparación entre CA125 y NT-proBNP para valorar la congestión en insuficiencia cardíaca aguda
29. Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction
30. Iron deficiency and short-term adverse events in patients with decompensated heart failure
31. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction
32. Carbohydrate antigen 125 in heart failure. A New era in the monitoring and control of treatment
33. Antígeno carbohidrato 125 en insuficiencia cardiaca. Nueva era en la monitorización y control del tratamiento
34. De novo acute heart failure: Clinical features and one-year mortality in the Spanish nationwide Registry of Acute Heart Failure
35. Insuficiencia cardiaca aguda de novo: características clínicas y mortalidad al año en el Registro Español de Insuficiencia Cardiaca Aguda
36. Digoxin and prognosis of heart failure in older patients with preserved ejection fraction: Importance of heart rate. Results from an observational and multicenter study
37. Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease.
38. Loop diuretic down‐titration at discharge in patients hospitalized for acute heart failure.
39. Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial‐IRON trial.
40. Pleural effusions in acute decompensated heart failure: Prevalence and prognostic implications
41. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction
42. Influencia de la fibrilación auricular en la mortalidad de los pacientes con insuficiencia cardiaca con fracción de eyección preservada
43. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design
44. Estrategias diuréticas en insuficiencia cardiaca aguda con disfunción renal: terapia convencional frente a guiada por el antígeno carbohidrato 125. Diseño de ensayo clínico
45. Trajectory of Urine Albumin-Creatinine Ratio in Patients with Acute Heart Failure.
46. Carbohydrate Antigen-125–Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study
47. Utility of the SENIORS elderly heart failure risk model applied to the RICA registry of acute heart failure
48. Prognostic Effect of Carbohydrate Antigen 125-guided Therapy in Patients Recently Discharged for Acute Heart Failure (CHANCE-HF). Study Design
49. Efecto pronóstico de una estrategia terapéutica guiada por los valores del antígeno carbohidrato 125 (CHANCE-HF). Diseño del estudio
50. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.